The company recorded healthy operating performance despite lower volume driven by savings in variable cost. Although Revenue/Ebitda/PAT degrew by 28%/31% and 60% on consolidated basis YoY on account of COVID-19 related lockdown, it recorded healthy EBITDA margin of 21.2% in line with our expectation